VolitionRX Limited
Organization details
- Legal name
- VolitionRX Limited
- Former names
- Standard Capital Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Henderson
- Headquarters state / province
- Nevada
- Headquarters country
- Singapore
- Fiscal year end
- December
- Ticker symbol
- VNRX
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0000093314
- EIN
- 91-1949078
Board of directors
-
Alan Colman · DirectorSince 2023
-
Cameron John Reynolds · Director · President and CEOSince 2023
-
Edward Futcher · DirectorSince 2023
-
Ethel Rubin · DirectorSince 2024
-
Guy Archibald Innes · DirectorSince 2023
-
Kim Nguyen · DirectorSince 2023
-
Martin Charles Faulkes · Director · Executive DirectorSince 2023
-
Mickie Henshall · DirectorSince 2023
-
Phillip Barnes · DirectorSince 2023
-
Richard Brudnick · DirectorSince 2023
-
Timothy I. Still · DirectorSince 2024
Chief executives
Director election results
Annual meeting of July 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.0%
-
92.0%
-
92.1%
-
94.4%
-
94.5%
-
95.1%
-
95.6%
Board connections
1 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
InflaRx N.V. Same sectorvia Richard Brudnick
-
Scholar Rock Holding Corporation Same sectorvia Richard Brudnick
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $7,000
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 21, 2026 | Batchelor Ann-Louise Officer (Group Chief Marketing Officer) | Grant or award | +12,000 | — | — |
| Sep 28, 2026 | Forterre Gael Officer (Chief Commercial Officer) | Shares withheld for tax | −284 | $0.25 | $71 |
| Sep 28, 2026 | Michel Gaetan Officer (Chief Operating Officer) | Shares withheld for tax | −608 | $0.25 | $152 |
| Mar 17, 2026 | Forterre Gael Officer (Chief Commercial Officer) | Shares withheld for tax | −5,251 | $0.19 | $998 |
| Mar 17, 2026 | Rootsaert Rodney Gerard Officer (Secretary) | Shares withheld for tax | −3,948 | $0.19 | $750 |
| Mar 17, 2026 | Plummer Nicholas Officer (GC - Volition Diagnostics) | Shares withheld for tax | −7,003 | $0.19 | $1,331 |
| Mar 17, 2026 | Micallef Jacob Vincent Officer (Chief Scientific Officer) | Shares withheld for tax | −5,310 | $0.19 | $1,009 |
| Mar 1, 2026 | Rootsaert Rodney Gerard Officer (Secretary) | Shares withheld for tax | −3,321 | $0.21 | $697 |
| Mar 1, 2026 | Forterre Gael Officer (Chief Commercial Officer) | Shares withheld for tax | −2,283 | $0.21 | $479 |
| Mar 1, 2026 | Plummer Nicholas Officer (GC - Volition Diagnostics) | Shares withheld for tax | −5,867 | $0.21 | $1,232 |
| Feb 26, 2026 | Forterre Gael Officer (Chief Commercial Officer) | Grant or award | +149,000 | — | — |
| Feb 26, 2026 | Ethel Rubin Director | Grant or award | +178,000 | — | — |
| Feb 26, 2026 | Cameron John Reynolds Director, Officer (President and CEO) | Grant or award | +486,000 | — | — |
| Feb 26, 2026 | Batchelor Ann-Louise Officer (Group Chief Marketing Officer) | Grant or award | +142,000 | — | — |
| Feb 26, 2026 | Hughes Terig Officer (Chief Financial Officer) | Grant or award | +202,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about VolitionRX Limited
Who is the CEO of VolitionRX Limited?
Cameron John Reynolds is VolitionRX Limited's President and CEO.
How many directors are on VolitionRX Limited's board?
VolitionRX Limited's board has 11 directors: Alan Colman, Cameron John Reynolds, Edward Futcher, Ethel Rubin, Guy Archibald Innes, Kim Nguyen, Martin Charles Faulkes, Mickie Henshall, Phillip Barnes, Richard Brudnick and 1 other.
Are VolitionRX Limited insiders buying or selling shares?
Over the last 12 months, VolitionRX Limited insiders bought $7,000 of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="volitionrx-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.